{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:07:37Z","timestamp":1789056457327,"version":"build-2803163510"},"reference-count":100,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Osteosarcoma(OS) exhibits poor and heterogeneous responses to immune checkpoint inhibitors(ICIs), largely due to its highly tumor immunosuppressive microenvironment(TIME). This review explores how nutritional biomarkers regulate the OS tumor microenvironment(TME) and serve as predictors of ICIs efficacy. Key biomarkers, including prognostic nutritional index(PNI), vitamin D and IDO modulate tumor-infiltrating lymphocytes (TILs), CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell function, macrophage polarization, and cytokine\u2013metabolite crosstalk through mechanisms such as nutrient depletion, lactate acidification, and inflammatory signaling. These biomarkers not only reflect host nutritional and inflammatory status but also actively shape an TIME that contributes to ICIs resistance. Targeted nutritional interventions and combinations with IDO show potential to reprogram the TME and enhance antitumor immunity. This review highlights the value of nutritional biomarkers for patient stratification, prognostic assessment, and the development of personalized nutrition\u2013immunotherapy strategies, providing a foundation for overcoming treatment resistance in OS.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1909913","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:25:25Z","timestamp":1789053925000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Nutritional biomarkers regulating tumor immune microenvironment in osteosarcoma and as predictors of immune checkpoint inhibitor responses"],"prefix":"10.3389","volume":"17","author":[{"given":"Haoyang","family":"Ren","sequence":"first","affiliation":[{"name":"Department of Foot and Ankle Surgery, Ningbo Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Ningbo No.6 Hospital","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengchun","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Foot and Ankle Surgery, Ningbo Clinical Research Center for Orthopedics, Sports Medicine & Rehabilitation, Ningbo No.6 Hospital","place":["Ningbo, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol Cancer"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra2103423","article-title":"New horizons in the treatment of osteosarcoma","volume":"385","author":"Meltzer","year":"2021","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.pbiomolbio.2025.07.001","article-title":"Advances and challenges in the treatment of osteosarcoma","volume":"197","author":"Wang","year":"2025","journal-title":"Prog Biophys Mol Biol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1394339","article-title":"Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies","volume":"12","author":"Liang","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2024.104575","article-title":"Chemotherapy, immunotherapy, and targeted therapy for osteosarcoma: Recent advancements","volume":"206","author":"Adewuyi","year":"2025","journal-title":"Crit Rev Oncol Hematol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.12.024","article-title":"Immunotherapy for osteosarcoma: fundamental mechanism, rationale, and recent breakthroughs","volume":"500","author":"Chen","year":"2021","journal-title":"Cancer Lett"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1584450","article-title":"Osteosarcoma immune microenvironment: cellular struggle and novel therapeutic insights","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41419-025-07903-7","article-title":"PDK1-dependent metabolic reprogramming regulates stemness and tumorigenicity of osteosarcoma stem cells through ATF3","volume":"16","author":"Tokumura","year":"2025","journal-title":"Cell Death Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1651858","article-title":"The osteosarcoma immune microenvironment in progression: PLEK as a prognostic biomarker and therapeutic target","volume":"16","author":"Zou","year":"2025","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202401343rrr","article-title":"TCF19\/CDKN2A regulates glycolysis and macrophage M2 polarization for osteosarcoma progression","volume":"39","author":"Hu","year":"2025","journal-title":"FASEB J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.28476","article-title":"Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma","volume":"234","author":"Huang","year":"2019","journal-title":"J Cell Physiol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12891-026-09494-6","article-title":"Correlation between systemic immune inflammatory index and prognostic nutritional index and prognosis of osteosarcoma patients and construction of prediction model","volume":"27","author":"Huang","year":"2026","journal-title":"BMC Musculoskelet Disord"},{"key":"B13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.nutres.2025.08.003","article-title":"Higher serum vitamin D concentration and supplementation were associated with improved survival outcomes and treatment response in cancer patients receiving immunotherapy: a systematic review and meta-analysis","volume":"141","author":"Yang","year":"2025","journal-title":"Nutr Res"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03522-3","article-title":"Systematic vitamin D supplementation is associated with improved outcomes and reduced thyroid adverse events in patients with cancer treated with immune checkpoint inhibitors: results from the prospective PROVIDENCE study","volume":"72","author":"Bersanelli","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-005670","article-title":"Serum albumin: a pharmacokinetic marker for optimizing treatment outcome of immune checkpoint blockade","volume":"10","author":"Zheng","year":"2022","journal-title":"J Immunother Cancer"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-024-00999-7","article-title":"Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways","volume":"31","author":"Wu","year":"2024","journal-title":"J BioMed Sci"},{"key":"B17","doi-asserted-by":"crossref","first-page":"100521","DOI":"10.1016\/j.jbo.2024.100521","article-title":"Reprogramming of glucose metabolism: metabolic alterations in the progression of osteosarcoma","volume":"44","author":"An","year":"2024","journal-title":"J Bone Oncol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/jfbc.14026","article-title":"The role of dietary polyphenols in osteosarcoma: a possible clue about the molecular mechanisms involved in a process that is just in its infancy","volume":"46","author":"Rabelo","year":"2022","journal-title":"J Food Biochem"},{"key":"B19","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1007\/s12032-025-03162-w","article-title":"Understanding the role of vitamin D in osteosarcoma: a narrative review","volume":"43","author":"Sulistyoningrum","year":"2025","journal-title":"Med Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1406","article-title":"Metabolism in cancer metastasis: bioenergetics, biosynthesis, and beyond","volume":"10","author":"Teoh","year":"2018","journal-title":"Wiley Interdiscip Rev Syst Biol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-20-1211","article-title":"Metabolic codependencies in the tumor microenvironment","volume":"11","author":"Dey","year":"2021","journal-title":"Cancer Discov"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202702","article-title":"Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells","volume":"191","author":"Husain","year":"2013","journal-title":"J Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic competition in the tumor microenvironment is a driver of cancer progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.08.012","article-title":"Phosphoenolpyruvate is a metabolic checkpoint of anti-tumor T cell responses","volume":"162","author":"Ho","year":"2015","journal-title":"Cell"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-019-0203-7","article-title":"Navigating metabolic pathways to enhance antitumour immunity and immunotherapy","volume":"16","author":"Li","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"B26","doi-asserted-by":"crossref","DOI":"10.3390\/nu7043011","article-title":"Vitamin D and 1,25(OH)2D regulation of T cells","volume":"7","author":"Cantorna","year":"2015","journal-title":"Nutrients"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01307","article-title":"Vitamin D controls tumor growth and CD8+ T cell infiltration in breast cancer","volume":"10","author":"Karkeni","year":"2019","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-3927","article-title":"Vitamin D-VDR signaling inhibits Wnt\/\u03b2-catenin-mediated melanoma progression and promotes antitumor immunity","volume":"79","author":"Muralidhar","year":"2019","journal-title":"Cancer Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-44110-6","article-title":"Vitamin D receptor (VDR) expression in osteosarcoma and its association with histological subtypes and metastasis","volume":"16","author":"Baly","year":"2026","journal-title":"Sci Rep"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1188641","article-title":"Vitamin D inhibits osteosarcoma by reprogramming nonsense-mediated RNA decay and SNAI2-mediated epithelial-to-mesenchymal transition","volume":"13","author":"Capobianco","year":"2023","journal-title":"Front Oncol"},{"key":"B31","article-title":"Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma","volume":"22","author":"Liebau","year":"2002","journal-title":"Anticancer Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-009-9290-7","article-title":"Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma","volume":"26","author":"Urakawa","year":"2009","journal-title":"Clin Exp Metastasis"},{"key":"B33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40364-023-00513-5","article-title":"Biomarkers for immune checkpoint inhibition in sarcomas - are we close to clinical implementation","volume":"11","author":"Yiong","year":"2023","journal-title":"biomark Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/ott.s494899","article-title":"Evaluation of indoleamine 2,3-dioxygenase (IDO) expression in osteosarcoma: insights from a 10-year retrospective cohort","volume":"18","author":"Farooq","year":"2025","journal-title":"Onco Targets Ther"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-001772","article-title":"Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes","volume":"9","author":"Ligon","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.18151","article-title":"Potential of inflammatory and nutritional markers and clinicopathological factors for prognostic prediction in osteosarcoma","volume":"46","author":"Hashimoto","year":"2026","journal-title":"Anticancer Res"},{"key":"B37","article-title":"Blockade of IGF\/IGF-1R signaling axis with soluble IGF-1R mutants suppresses the cell proliferation and tumor growth of human osteosarcoma","volume":"10","author":"Cao","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.gendis.2014.10.004","article-title":"Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance","volume":"2","author":"Denduluri","year":"2015","journal-title":"Genes Dis"},{"key":"B39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s43018-019-0007-9","article-title":"Short-term starvation reduces IGF-1 levels to sensitize lung tumors to PD-1 immune checkpoint blockade","volume":"1","author":"Ajona","year":"2020","journal-title":"Nat Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/mc.21940","article-title":"Decreased systemic IGF-1 in response to calorie restriction modulates murine tumor cell growth, nuclear factor-\u03baB activation, and inflammation-related gene expression","volume":"52","author":"Harvey","year":"2013","journal-title":"Mol Carcinog"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-014601","article-title":"Epigenetic remodeling in sarcoma promotes T-cell infiltration via modulation of the Hippo pathway","volume":"14","author":"Cruz De Los Santos","year":"2026","journal-title":"J Immunother Cancer"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/6563609","article-title":"The prognostic model established by the differential expression genes based on CD8(+) T cells to evaluate the prognosis and the response to immunotherapy in osteosarcoma","volume":"2023","author":"Chen","year":"2023","journal-title":"Mediators Inflammation"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.709210","article-title":"Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"9769","DOI":"10.1038\/s41598-024-60539-z","article-title":"Importance of CD8 Tex cell-associated gene signatures in the prognosis and immunology of osteosarcoma","volume":"14","author":"Lu","year":"2024","journal-title":"Sci Rep"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.21037\/atm-21-3928","article-title":"T cell exhaustion drives osteosarcoma pathogenesis","volume":"9","author":"Sun","year":"2021","journal-title":"Ann Transl Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-025-01415-6","article-title":"Dietary restriction reprograms CD8(+) T cell fate to enhance anti-tumour immunity and immunotherapy responses","volume":"7","author":"Oswald","year":"2025","journal-title":"Nat Metab"},{"key":"B47","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12943-025-02516-2","article-title":"Targeting OxLDL-mediated CD36\u2009+\u2009CAF reprogramming potentiates PD-1 immunotherapy in osteosarcoma","volume":"25","author":"Zeng","year":"2025","journal-title":"Mol Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101977","article-title":"Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma","volume":"6","author":"Mu","year":"2025","journal-title":"Cell Rep Med"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002840","article-title":"Tryptophan potentiates CD8(+) T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation","volume":"9","author":"Qin","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2025.114492","article-title":"Glycolysis-related gene signatures and the functional role of P4HA1 in osteosarcoma prognosis","volume":"447","author":"Gui","year":"2025","journal-title":"Exp Cell Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.2147\/itt.s485672","article-title":"Myeloid cells in the immunosuppressive microenvironment as immunotargets in osteosarcoma","volume":"14","author":"Sholevar","year":"2025","journal-title":"Immunotargets Ther"},{"key":"B52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41413-023-00246-z","article-title":"Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment","volume":"11","author":"Tian","year":"2023","journal-title":"Bone Res"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-026-04288-5","article-title":"Macrophage-centered immunotherapy for osteosarcoma: mechanisms, repolarization, and translational strategies","volume":"24","author":"Li","year":"2026","journal-title":"World J Surg Oncol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17132117","article-title":"Immunosuppressive tumor microenvironment of osteosarcoma","volume":"17","author":"Taylor","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1394284","article-title":"Unlocking the tumor-immune microenvironment in osteosarcoma: insights into the immune landscape and mechanisms","volume":"15","author":"Orrapin","year":"2024","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002426","article-title":"Metabolic reprogramming in the immunosuppression of tumor-associated macrophages","volume":"135","author":"Wang","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114504","article-title":"The role of metabolic reprogramming of tumor-associated macrophages in shaping the immunosuppressive tumor microenvironment","volume":"161","author":"Li","year":"2023","journal-title":"BioMed Pharmacother"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.mct-20-0591","article-title":"CSF1\/CSF1R signaling inhibitor pexidartinib (PLX3397) reprograms tumor-associated macrophages and stimulates T-cell infiltration in the sarcoma microenvironment","volume":"20","author":"Fujiwara","year":"2021","journal-title":"Mol Cancer Ther"},{"key":"B59","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.livres.2025.10.001","article-title":"Cancer cachexia-related monocytic myeloid-derived suppressor cells impair T-cell negative selection and predict immune-related adverse events","volume":"9","author":"Wei","year":"2025","journal-title":"Liver Res"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.883308","article-title":"A nutritional metabolism related prognostic scoring system for patients with newly diagnosed osteosarcoma","volume":"9","author":"Li","year":"2022","journal-title":"Front Nutr"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2023.2280002","article-title":"Predictive value of immunotherapy-induced inflammation indexes: dynamic changes in patients with nasopharyngeal carcinoma receiving immune checkpoint inhibitors","volume":"55","author":"Cao","year":"2023","journal-title":"Ann Med"},{"key":"B62","doi-asserted-by":"crossref","DOI":"10.2147\/OTT.S287192","article-title":"Prognostic value of the preoperative lymphocyte-to-C-reactive protein ratio and albumin-to-globulin ratio in patients with osteosarcoma","volume":"13","author":"Hu","year":"2020","journal-title":"Onco Targets Ther"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112276","article-title":"Combining dynamics of serum inflammatory and nutritional indicators as novel biomarkers in immune checkpoint inhibitor treatment of non-small-cell lung cancer with bone metastases","volume":"136","author":"Asano","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e27282","article-title":"Predictive impact of sarcopenia in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: a retrospective study","volume":"10","author":"Feng","year":"2024","journal-title":"Heliyon"},{"key":"B65","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.lungcan.2019.08.006","article-title":"Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors","volume":"136","author":"Shoji","year":"2019","journal-title":"Lung Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/ijc.70170","article-title":"Prospective validation study of nutritional and immunological predictors in immune checkpoint inhibitor efficacy for non-small cell lung cancer","volume":"158","author":"Takamori","year":"2026","journal-title":"Int J Cancer"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2026.101142","article-title":"Durable clinical benefit and progression-free survival in patients with PD-L1 \u226550% NSCLC receiving pembrolizumab: impact of nutritional and inflammatory markers","volume":"47","author":"Yamakawa","year":"2026","journal-title":"Cancer Treat Res Commun"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3390\/nu14071354","article-title":"Vitamin D and its target genes","volume":"14","author":"Carlberg","year":"2022","journal-title":"Nutrients"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114735","article-title":"Vitamin D and the risk for cancer: a molecular analysis","volume":"196","author":"Carlberg","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003017","article-title":"Toll-like receptor 8 ligands activate a vitamin D mediated autophagic response that inhibits human immunodeficiency virus type 1","volume":"8","author":"Campbell","year":"2012","journal-title":"PloS Pathog"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2022.2056574","article-title":"Association between vitamin D supplementation and cancer incidence and mortality: a trial sequential meta-analysis of randomized controlled trials","volume":"63","author":"Guo","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/85.6.1586","article-title":"Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial","volume":"85","author":"Lappe","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.19369","article-title":"A prognostic glycolysis-related gene signature in osteosarcoma: implications for metabolic programming, immune microenvironment, and drug response","volume":"13","author":"Zhu","year":"2025","journal-title":"PeerJ"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000010741","article-title":"Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma","volume":"97","author":"Fu","year":"2018","journal-title":"Med (Baltimore)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-014-1644-0","article-title":"Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis","volume":"140","author":"Chen","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc.2016.71","article-title":"From Krebs to clinic: glutamine metabolism to cancer therapy","volume":"16","author":"Altman","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-020-0209-8","article-title":"Glutaminase-1 (GLS1) inhibition limits metastatic progression in osteosarcoma","volume":"8","author":"Ren","year":"2020","journal-title":"Cancer Metab"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-024-00967-1","article-title":"Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma","volume":"47","author":"Wang","year":"2024","journal-title":"Cell Oncol (Dordr)"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.2174\/1566524021666211004112055","article-title":"miR-141-3p promotes the cisplatin sensitivity of osteosarcoma cell through targeting the glutaminase [GLS]-mediated glutamine metabolism","volume":"23","author":"Zhou","year":"2023","journal-title":"Curr Mol Med"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1126\/science.aav2588","article-title":"Glutamine blockade induces divergent metabolic programs to overcome tumor immune evasion","volume":"366","author":"Leone","year":"2019","journal-title":"Science"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2022.2062875","article-title":"Glutamine, MTOR and autophagy: a multiconnection relationship","volume":"18","author":"Bodineau","year":"2022","journal-title":"Autophagy"},{"key":"B83","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1016\/j.cell.2018.10.001","article-title":"Distinct regulation of Th17 and Th1 cell differentiation by glutaminase-dependent metabolism","volume":"175","author":"Johnson","year":"2018","journal-title":"Cell"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2024.02.023","article-title":"Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer","volume":"68","author":"Li","year":"2025","journal-title":"J Adv Res"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-020-1703-2","article-title":"Glutamine metabolism in Th17\/Treg cell fate: applications in Th17 cell-associated diseases","volume":"64","author":"Yang","year":"2021","journal-title":"Sci China Life Sci"},{"key":"B86","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.trecan.2021.04.003","article-title":"Enhancing the efficacy of glutamine metabolism inhibitors in cancer therapy","volume":"7","author":"Yang","year":"2021","journal-title":"Trends Cancer"},{"key":"B87","doi-asserted-by":"publisher","first-page":"4011","DOI":"10.1038\/s41467-020-17750-z","article-title":"Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-kynurenine","volume":"11","author":"Campesato","year":"2020","journal-title":"Nat Commun"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.08.077","article-title":"Tumor-expressed IDO recruits and activates MDSCs in a Treg-dependent manner","volume":"13","author":"Holmgaard","year":"2015","journal-title":"Cell Rep"},{"key":"B89","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.it.2016.01.002","article-title":"IDO in the tumor microenvironment: inflammation, counter-regulation, and tolerance","volume":"37","author":"Munn","year":"2016","journal-title":"Trends Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1186\/s12967-022-03554-w","article-title":"IDO\/kynurenine pathway in cancer: possible therapeutic approaches","volume":"20","author":"Abd El-Fattah","year":"2022","journal-title":"J Transl Med"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1632446","article-title":"IDO and TDO inhibitors in cancer immunotherapy: mechanisms, clinical development, and future directions","volume":"16","author":"Al-Zoubi","year":"2025","journal-title":"Front Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11071988","article-title":"Indoleamine 2,3-dioxygenase (IDO) activity: a perspective biomarker for laboratory determination in tumor immunotherapy","volume":"11","author":"Yang","year":"2023","journal-title":"Biomedicines"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01185","article-title":"Immunosuppressive IDO in cancer: mechanisms of action, animal models, and targeting strategies","volume":"11","author":"Zhai","year":"2020","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102461","article-title":"Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy","volume":"110","author":"Fujiwara","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121018","article-title":"Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy","volume":"276","author":"Guo","year":"2021","journal-title":"Biomaterials"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.37029\/jcas.v9i1.501","article-title":"Indoleamine 2,3-dioxygenase: a novel immunotherapeutic target for osteosarcoma","volume":"9","author":"Farooq","year":"2023","journal-title":"J Cancer Allied Spec"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100675","article-title":"Combination of IDO inhibitors and platinum(IV) prodrugs reverses low immune responses to enhance cancer chemotherapy and immunotherapy for osteosarcoma","volume":"20","author":"Xiang","year":"2023","journal-title":"Mater Today Bio"},{"key":"B98","doi-asserted-by":"crossref","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodr\u00edguez","year":"2008","journal-title":"Immunol Rev"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c05408","article-title":"Arginine supplementation targeting tumor-killing immune cells reconstructs the tumor microenvironment and enhances the antitumor immune response","volume":"16","author":"Zhang","year":"2022","journal-title":"ACS Nano"},{"key":"B100","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/15384047.2016.1276136","article-title":"Combination therapy with L-arginine and \u03b1-PD-L1 antibody boosts immune response against osteosarcoma in immunocompetent mice","volume":"18","author":"He","year":"2017","journal-title":"Cancer Biol Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1909913\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T15:25:27Z","timestamp":1789053927000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1909913\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":100,"alternative-id":["10.3389\/fimmu.2026.1909913"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1909913","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"article-number":"1909913"}}